Copyright 2001 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
To the Editor: Antimicrobial resistance is an increasing problem in the treatment of infections due to Streptococcus pneumoniae.1 Such resistance has also recently been reported in the United States among the viridans group of streptococci, especially Streptococcus mitis.2 We report a case of subacute bacterial endocarditis in a child, resulting from an infection caused by S mitis that was fully resistant to penicillin and ceftriaxone.
A 22-month-old black male with a known history of a perimembranous ventricular septal defect was admitted to our hospital with a 10-day history of fever and irritability. The patient had otherwise been healthy. Both blood cultures drawn on admission grew S mitis. The sensitivity analyses showed a minimal inhibitory concentration (MIC) to penicillin of 4 µg/mL, an MIC to ceftriaxone of 4 µg/mL, and an MIC to vancomycin of 0.5 µg/mL or less. Transthoracic echocardiography revealed a large vegetation on the tricuspid valve.
The patient was treated with intravenous vancomycin (60 mg/kg per day) and ceftriaxone (100 mg/kg per day) for 6 weeks, as well as gentamicin (3 mg/kg per day) for the first 4 weeks of therapy. The results of blood cultures were negative 48 hours after initiation of antimicrobial therapy. Three weeks following the completion of antimicrobial therapy, the patient underwent primary closure of the ventricular septal defect and removal of the vegetation from the tricuspid valve. Gram staining and culture from the vegetation failed to reveal an organism and the pathology findings were consistent with acute and chronic inflammation. The patient remains clinically well 9 months after therapy.
We believe this is the first report of a healthy child with endocarditis caused by viridans streptococci with high-level resistance to penicillin and ceftriaxone. Group day care attendance was the only risk factor that we could elicit for multidrug-resistant infection. Endocarditis caused by viridans streptococci with high-level resistance to penicillin and cefotaxime was reported in an adult with human immunodeficiency virus infection (HIV).3 Additionally, Levitz4 reported an HIV-infected adult with prosthetic valve endocarditis caused by pencillin-resistant S mitis.
Because the optimal antibiotic therapy for endocarditis caused by resistant viridans streptococci is not known, it will be important to report clinical experiences with such cases in the hope that rational treatment recommendations can be developed.
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Journal of American Medical Association editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.